Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Goldstein

Showing results (321-330 of 518) with videos related to

Pageof 52
Sort By:
Scientific Reports|November 25, 2021
Corneal dendritic cells and the subbasal nerve plexus following neurotoxic treatment with oxaliplatin or paclitaxelJeremy Chung Bo Chiang, David Goldstein, Azadeh Tavakoli, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|May 23, 2022
Psychological outcomes in advanced cancer patients after receiving genomic tumor profiling resultsSabina Vatter, Timothy E Schlub, Christine E Napier, et al.
Pancreas|December 8, 2017
Biliary Stenting in Patients With Pancreatic Cancer: Results From a Population-Based Cohort StudyMadeleine Payne, Elizabeth A Burmeister, Mary Waterhouse, et al.
JCO Precision Oncology|May 1, 2024
Plasma Lipidomic Profiling Identifies Elevated Triglycerides as Potential Risk Factor in Chemotherapy-Induced Peripheral NeuropathyNicole Yeung, Tiffany Li, Hui-Ming Lin, et al.
Pancreas|August 12, 2015
Describing Patterns of Care in Pancreatic Cancer: A Population-Based StudyElizabeth A Burmeister, Dianne L OʼConnell, Vanessa L Beesley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2009
Treatment of fluorouracil-refractory patients with liver metastases from colorectal cancer by using yttrium-90 resin microspheres plus concomitant systemic irinotecan chemotherapyGuy A van Hazel, Nick Pavlakis, David Goldstein, et al.
The Australian Journal of Rural Health|February 18, 2015
Oncology service initiatives and research in regional AustraliaCaitlin Murphy, Sabe Sabesan, Christopher Steer, et al.
Journal of Translational Medicine|December 6, 2022
Polygenic risk of paclitaxel-induced peripheral neuropathy: a genome-wide association studyKosar Hooshmand, David Goldstein, Hannah C Timmins, et al.
Patient Education and Counseling|April 2, 2013
Should culture affect practice? A comparison of prognostic discussions in consultations with immigrant versus native-born cancer patientsPhyllis N Butow, Ming Sze, Maurice Eisenbruch, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 15, 2023
Patient-Reported Outcome Measures in Chemotherapy-Induced Peripheral Neurotoxicity: Defining Minimal and Clinically Important ChangesTiffany Li, Hannah C Timmins, Terry Trinh, et al.
Pageof 52

Showing results (321-330 of 518) with videos related to

Sort By:
Pageof 52
Scientific Reports|November 25, 2021
Corneal dendritic cells and the subbasal nerve plexus following neurotoxic treatment with oxaliplatin or paclitaxelJeremy Chung Bo Chiang, David Goldstein, Azadeh Tavakoli, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|May 23, 2022
Psychological outcomes in advanced cancer patients after receiving genomic tumor profiling resultsSabina Vatter, Timothy E Schlub, Christine E Napier, et al.
Pancreas|December 8, 2017
Biliary Stenting in Patients With Pancreatic Cancer: Results From a Population-Based Cohort StudyMadeleine Payne, Elizabeth A Burmeister, Mary Waterhouse, et al.
JCO Precision Oncology|May 1, 2024
Plasma Lipidomic Profiling Identifies Elevated Triglycerides as Potential Risk Factor in Chemotherapy-Induced Peripheral NeuropathyNicole Yeung, Tiffany Li, Hui-Ming Lin, et al.
Pancreas|August 12, 2015
Describing Patterns of Care in Pancreatic Cancer: A Population-Based StudyElizabeth A Burmeister, Dianne L OʼConnell, Vanessa L Beesley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2009
Treatment of fluorouracil-refractory patients with liver metastases from colorectal cancer by using yttrium-90 resin microspheres plus concomitant systemic irinotecan chemotherapyGuy A van Hazel, Nick Pavlakis, David Goldstein, et al.
The Australian Journal of Rural Health|February 18, 2015
Oncology service initiatives and research in regional AustraliaCaitlin Murphy, Sabe Sabesan, Christopher Steer, et al.
Journal of Translational Medicine|December 6, 2022
Polygenic risk of paclitaxel-induced peripheral neuropathy: a genome-wide association studyKosar Hooshmand, David Goldstein, Hannah C Timmins, et al.
Patient Education and Counseling|April 2, 2013
Should culture affect practice? A comparison of prognostic discussions in consultations with immigrant versus native-born cancer patientsPhyllis N Butow, Ming Sze, Maurice Eisenbruch, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 15, 2023
Patient-Reported Outcome Measures in Chemotherapy-Induced Peripheral Neurotoxicity: Defining Minimal and Clinically Important ChangesTiffany Li, Hannah C Timmins, Terry Trinh, et al.
Pageof 52